Claire Lafay‐Chebassier

mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP‐PS1 transgenic models and in patients with Alzheimer's disease

Claire Lafay‐Chebassier, Marc Paccalin, Guylène Page et al. · Journal of Neurochemistry · 2005 · 211 citations · Full text

Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer’s disease

Guylène Page, Agnès Rioux Bilan, Sabrina Ingrand et al. · Neuroscience · 2006 · 110 citations

Synaptic Plasticity, Neurodegenerative Diseases, Molecular Neuroscience +13

Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database

François Chavant, Sylvie Favrelière, Claire Lafay‐Chebassier et al. · British Journal of Clinical Pharmacology · 2011 · 89 citations · Full text

The oxindole/imidazole derivative C16 reduces in vivo brain PKR activation

Sabrina Ingrand, Laurence Barrier, Claire Lafay‐Chebassier et al. · FEBS Letters · 2007 · 88 citations

Imipramine, in Part through Tumor Necrosis Factor α Inhibition, Prevents Cognitive Decline and β-Amyloid Accumulation in a Mouse Model of Alzheimer's Disease

François Chavant, Julie Deguil, Stéphanie Pain et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 71 citations